Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.

Davis JE, Sherritt MA, Bharadwaj M, Morrison LE, Elliott SL, Kear LM, Maddicks-Law J, Kotsimbos T, Gill D, Malouf M, Falk MC, Khanna R, Moss DJ.

Int Immunol. 2004 Jul;16(7):983-9. Epub 2004 May 24.

PMID:
15159377
2.

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.

Sherritt MA, Bharadwaj M, Burrows JM, Morrison LE, Elliott SL, Davis JE, Kear LM, Slaughter RE, Bell SC, Galbraith AJ, Khanna R, Moss DJ.

Transplantation. 2003 May 15;75(9):1556-60.

PMID:
12792514
3.

Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.

Silins SL, Sherritt MA, Silleri JM, Cross SM, Elliott SL, Bharadwaj M, Le TT, Morrison LE, Khanna R, Moss DJ, Suhrbier A, Misko IS.

Blood. 2001 Dec 15;98(13):3739-44.

PMID:
11739180
4.

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines.

Sherritt MA, Gardner J, Elliott SL, Schmidt C, Purdie D, Deliyannis G, Heath WR, Suhrbier A.

Eur J Immunol. 2000 Feb;30(2):671-7.

5.

Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.

Thomson SA, Sherritt MA, Medveczky J, Elliott SL, Moss DJ, Fernando GJ, Brown LE, Suhrbier A.

J Immunol. 1998 Feb 15;160(4):1717-23.

6.

Use of recombinant vaccinia to restimulate antigen specific human peripheral blood cytotoxic T lymphocytes.

Gardner J, Khanna R, Sherritt MA, Suhrbier A.

J Virol Methods. 1997 Apr;65(1):105-9.

PMID:
9128867
7.

The effect of HLA-DRB1 disease susceptibility markers on the expression of RA.

Rowley MJ, Stockman A, Brand CA, Tait BD, Rowley GL, Sherritt MA, Mackay IR, Muirden KD, Bernard CC.

Scand J Rheumatol. 1997;26(6):448-55.

PMID:
9433406
8.

Immunosusceptibility genes in rheumatoid arthritis.

Sherritt MA, Tait B, Varney M, Kanaan C, Stockman A, Mackay IR, Muirden K, Bernard CC, Rowley MJ.

Hum Immunol. 1996 Nov;51(1):32-40.

PMID:
8911995
9.

Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.

Thomson SA, Elliott SL, Sherritt MA, Sproat KW, Coupar BE, Scalzo AA, Forbes CA, Ladhams AM, Mo XY, Tripp RA, Doherty PC, Moss DJ, Suhrbier A.

J Immunol. 1996 Jul 15;157(2):822-6.

PMID:
8752934
10.

Influence of HLA-DR2, HLA-DPw4, and T cell receptor alpha chain genes on the susceptibility to multiple sclerosis.

Sherritt MA, Oksenberg J, de Rosbo NK, Bernard CC.

Int Immunol. 1992 Feb;4(2):177-81.

PMID:
1352460

Supplemental Content

Loading ...
Support Center